Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Amicus Therapeutics (FOLD) over the last 10 years, with Q3 2025 value amounting to $36.3 million.

  • Amicus Therapeutics' Change in Inventory rose 458.09% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.2 million, marking a year-over-year increase of 2373.58%. This contributed to the annual value of $73.7 million for FY2024, which is 6508.72% up from last year.
  • As of Q3 2025, Amicus Therapeutics' Change in Inventory stood at $36.3 million, which was up 458.09% from $22.6 million recorded in Q2 2025.
  • Amicus Therapeutics' Change in Inventory's 5-year high stood at $36.3 million during Q3 2025, with a 5-year trough of -$1.8 million in Q1 2022.
  • In the last 5 years, Amicus Therapeutics' Change in Inventory had a median value of $5.2 million in 2021 and averaged $10.5 million.
  • Its Change in Inventory has fluctuated over the past 5 years, first plummeted by 39521.91% in 2021, then soared by 151014.49% in 2023.
  • Amicus Therapeutics' Change in Inventory (Quarter) stood at $4.8 million in 2021, then surged by 115.1% to $10.3 million in 2022, then tumbled by 76.78% to $2.4 million in 2023, then skyrocketed by 404.83% to $12.0 million in 2024, then soared by 202.18% to $36.3 million in 2025.
  • Its last three reported values are $36.3 million in Q3 2025, $22.6 million for Q2 2025, and $8.3 million during Q1 2025.